---

	1. The examination of the progressive renal cell carcinoma case that brain metastasis was found out during molecular target drug administration Hidehiko Yoshii, Keiichi Ito, 田崎新資, Kenji Kuroda, 佐藤全伯, Morning dark circles Junichi, Akio Horiguchi, Takeshi Seguchi solstice, Makoto Sumitomo, Masamichi Hayakawa, Tomohiko Asano Japanese Society of Renal Cancer meeting program 41(suppl): 9-9, 2011.

---

	2. About C-reactive protein(CRP) kinetics: CRP progression-free survival(CRP-PFS) in the molecular target treatment and a correlation with the overall survival Kazutaka Saito, Manabu Tadokoro, 藤井靖久, Fumitaka Koga, Hitoshi Masuda, Kazunori Kihara Japanese Society of Renal Cancer meeting program 41(suppl): 10-10, 2011.

---

	3. A trial of the optimal dose setting that there are few a little foreign beginning of dosage of the molecular target medicine and dropout cases by the upward dose titration 徳田倫章, Futoshi Morokuma, 狩野武洋, 杉本昌顕, Hidenori Iwai, Takeshi Kobayashi Japanese Society of Renal Cancer meeting program 41(suppl): 11-11, 2011.

---

	4. Experience of the treatment with molecular target medicine for primary tumor excision inability renal cell carcinoma Akihisa Yao, Hideto Iwamoto, Seiya Inoue, Mayuko Matsumoto, 森實修一, Nobuyuki Hiuga, Masashi Honda, Tadahiro Isoyama, Tsounapi Panagiota, 瀬島健裕, 武中篤 Japanese Society of Renal Cancer meeting program 41(suppl): 12-12, 2011.

---

5. Is the antitumor effect of the Sioux tent for the lung alone metastasis the overseas third phase study in patients with metastatic renal cell carcinoma of the Sioux tent and the subanalysis of domestic second phase test results Hideyuki Akaza, Nobuo Shinohara 1, Takeshi Yuasa 2, Yoshihiko Tomita 3, Hiroyuki Fujimoto 4, Garden river 5 required, Mugidani Soichi 6, Seiichiro Osono 6, Koji Miki 7, Uemura sky tray 8, Nonomura celebration husband 9, Masayuki Takahashi 10, Shuku Hasegawa Expo 11, Naoki Aga 12, Takashi Kano British 12, Eiji Ueda 12, Atsushi Shibata 12, 河合統介 12, Seiji Naito 13 Japanese Society of Renal Cancer meeting program 41(suppl): 13-14, 2011.

---

	6. Three cases of tyrosine kinase inhibitor-related gastrointestinal complications in the treatment of the progressive renal carcinoma Takaaki Inoue, Hidefumi Kinoshita, 駒井資弘, Masayuki Nakagawa, Kazushi Kawabata, River source, Tadashi Matsuda Japanese Society of Renal Cancer meeting program 41(suppl): 15-16, 2011.

---

	7. Two patients who presented with gastrointestinal perforation in the sunitinib administration Yasuyuki Seno, Akira Kato life, Koji Mita Japanese Society of Renal Cancer meeting program 41(suppl): 17-17, 2011.

---

	8. Two cases that caused bowel perforation during Sunitinib administration Tsuyoshi Kaneko 1), Ryuichi Mizuno 1), Eiji Kikuchi 1), Shuji Mikami 2), Kazunobu Shinoda 1), Kono 1, Hidaka), Hirohiko Nagata 1), Hiroshi Asanuma 1), Tetsu Miyajima 1), Takeshi Nakagawa 1), Mototsugu Oya 1) Japanese Society of Renal Cancer meeting program 41(suppl): 18-19, 2011.

---

	9. Five cases that suffered from the unexpected adverse event that developed after molecular target treatment Masahiro Yanase, Nishiyama Naotaka, Island Masaki, Shunsuke Sato, Manabu Okada Japanese Society of Renal Cancer meeting program 41(suppl): 20-20, 2011.

---

	10. One case of the metastatic renal cell carcinoma which developed ileus during sunitinib administration Living in peace truth, Pond Castle table, Three wave Keita, 原林透, Satoshi Nagamori Japanese Society of Renal Cancer meeting program 41(suppl): 21-21, 2011.

---

	11. About rash - erythema multiforme by sorafenib for progressive renal cell carcinoma - 池田勝臣 1), Masatsugu Iwamura 1), Jun Mitsui snow 2), Kenichi Tabata 1), Tetsuo Fujita 1), Kenichi Tanabe 2), Shiro Baba 1) Japanese Society of Renal Cancer meeting program 41(suppl): 22-22, 2011.

---

	12. Two cases of progressive renal cell carcinoma that a cryotherapy was effective for stomatitis by the temsirolimus 小中弘之, 飯島将司, 栗林正人, 前田雄司, 北川育秀, 並木幹夫 Japanese Society of Renal Cancer meeting program 41(suppl): 23-23, 2011.

---

	13. The case that they presented with acute renal failure during sunitinib administration, and caused nephropathic revival after Everolimus administration 加藤廉平, 小原航, 佐藤健介, 藤島洋介, 高田亮, 大森聡, 藤岡知昭 Japanese Society of Renal Cancer meeting program 41(suppl): 24-24, 2011.

---

	14. Impaired renal function by the Everolimus 楠田雄司, 酒井伊織, 寺川智章, 古川順也, 原田健一, 村蒔基次, 三宅秀明, 藤澤正人 Japanese Society of Renal Cancer meeting program 41(suppl): 25-25, 2011.

---

	15. One case that presented Guillain-Barre syndrome and tumor lysis syndrome after sunitinib internal use for bilateral renal carcinoma Takashi Hasegawa High School, Masahiro Matsumoto, Takashi Hamazaki, Hama sand Ryoichi, 藤本直浩, Tetsuro Matsumoto Japanese Society of Renal Cancer meeting program 41(suppl): 26-26, 2011.

---

16. The examination of the renal carcinoma case forced to cancellation of the tyrosine kinase inhibitor administration by by an adverse event 亭島淳, Takahiro Yuhei, Kohei Obata, Hideo Iwamoto, Volost power Akihiro, Path of righteousness Koichi, Makoto Oki fruit, Hiroshi Masumoto, Katsutoshi Miyamoto, Shogo Inoue, 小林加直, Mitsuru Kajiwara, Akio Matsubara Japanese Society of Renal Cancer meeting program 41(suppl): 27-27, 2011.

---

	17. One patient who presented with pulmonary haemorrhage all over the use of sunitinib course, and died 常森寛行 1), Yasuyuki Miyauchi 1), Toshifumi Yano 1), Hiromi Hirama 1), Takuma Kato 1), 山下資樹 1), 山本議仁 2), Masashi Inui 1), History of Miki Sugimoto 1), Water pipe 1, Zengyo) Japanese Society of Renal Cancer meeting program 41(suppl): 28-28, 2011.

---

	18. Examination about the thyroid atrophy caused by the Sunitinib administration for the renal cancer patients Nobuo Shinohara 1), Masayuki Takahashi 2), Satoru Maruyama 1), Abe adoration 1), 佐澤陽 1), Hiroomi Kanayama 2), Katsuya Nonomura 1) Japanese Society of Renal Cancer meeting program 41(suppl): 29-29, 2011.

---

	19. One case of the renal carcinoma metastases to spine that suffered from treatment with sunitinib Yoshio Naya, Middle ノ 内恒如, 萩原暢久, Well book proton, Hidetake Fujii, Ichiro Takeuchi, Masaru Mori Japanese Society of Renal Cancer meeting program 41(suppl): 30-30, 2011.

---

	20. One patient who progressive renal cell carcinoma was diagnosed, and had a diagnosis of malignant lymphoma after treatment with molecular target medicine by Necropsy Tatsuya Takayama, Takayuki Sugiyama, Worth sentence length, Mugidani Soichi, Seiichiro Osono Japanese Society of Renal Cancer meeting program 41(suppl): 31-31, 2011.

---

	Respiratory adverse event measures of the mTOR inhibitor in the progressive renal carcinoma Takeshi Ueda 1), 新行内雅斗 2), Hiroyuki Funatsu 3), Eri Shiota 1), Kyoko Miyasaka 1), Masayuki Kobayashi 1), 小丸淳 1), Masaru Fukazawa 1), Egoe Kenichi 1), Akashi Itakura 2), Hideyuki Takano 3), Masayuki Maruoka 1) Japanese Society of Renal Cancer meeting program 41(suppl): 32-32, 2011.

---

	One patient whom interstitial pneumonia was suspected in by monitoring of KL6 during Everolimus administration 若松太郎, 近藤恒徳, 小林博人, 飯塚淳平, 冨田英里, 高木敏男, 田邉一成 Japanese Society of Renal Cancer meeting program 41(suppl): 33-33, 2011.

---

	One case that suffered from differentiation of interstitial pneumonia and the lymphangitis carcinomatosis Yukio Naya, Chihiro Araki, Person of Kaga perception, Masahiko Inahara, Satoko Kojima, Kazuyoshi Nakamura *, Shinichi Sakamoto *, Mountain of many hawks' nests Takahito *, Naoki Nihei *, Tomohiko Ichikawa * Japanese Society of Renal Cancer meeting program 41(suppl): 34-34, 2011.

---